OPTIONS – December 2017

December 20, 2017

The OPTIONS Consortium objective is to develop a streamlined, adaptable product delivery platform for current and future ARV-based HIV prevention options, with a particular focus on women. OPTIONS develops communication strategy for Lesotho’s oral PrEP roll out. OPTIONS hosts dapivirine ring modeling stakeholder consultation. Operations research underway. PrEPWatch re-organized and new resources added. Mapping of… Read more »

Read more >

GEMS – September 2017

September 13, 2017

GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance. Drug-resistance testing in Kenya progresses. GEMS prepares for drug-resistance testing in South Africa and Zimbabwe. Genital swabs testing begins and assay development is underway. Oral PrEP modeling continues. Drug-resistance testing in Kenya progresses. The GEMS team… Read more »

Read more >

CHARISMA – September 2017

September 13, 2017

CHARISMA supports efforts to: increase women’s agency to safely use ARV-based HIV prevention, to engage male partners in HIV prevention, and to overcome harmful gender norms and reduce intimate partner violence (IPV). Clinic- and community-based interventions continue. Intervention evaluations and reporting planned. Clinic- and community-based interventions continue. CHARISMA is piloting its clinic-based intervention as part… Read more »

Read more >

EMOTION – September 2017

September 13, 2017

EMOTION increases uptake and correct and consistent use of ARV-based HIV prevention products by women at high risk of HIV infection using an end-user centered strategy. Project VOGUE underway. Project VOGUE underway. EMOTION is currently preparing for Project VOGUE, a socio-behavioral study comparing the human-centered design (HCD)-branded experience and product to unbranded product and standard… Read more »

Read more >

POWER – September 2017

September 13, 2017

POWER develops cost-effective and scalable models for implementation of ARV-based HIV prevention products for women. My PrEP decision support tool in production with additional demand creation tools in development. Final formative report completed. Cohorts in Cape Town, Johannesburg, and Kisumu launched. My PrEP decision support tool in production with additional demand creation tools in development…. Read more »

Read more >

OPTIONS – September 2017

September 13, 2017

The OPTIONS Consortium objective is to develop a streamlined, adaptable product delivery platform for current and future ARV-based HIV prevention options, with a particular focus on women. Plan 4 PrEP Toolkit offers support for oral PrEP introduction. OPTIONS and IPM collaborate to make the case for the dapivirine ring. Private sector landscape analysis supports country… Read more »

Read more >

MPii presents at three international conferences

September 13, 2017

MPii participated in three international conferences, presenting results from several different areas of work. At the South Africa AIDS Conference in June, OPTIONS presented posters about its iterative process to create information, education, and communication (IEC) materials for the launch of oral PrEP at sex worker sites, as well as efforts to collect additional evidence… Read more »

Read more >

MPii supports Namibia’s efforts for accelerated introduction of HIV prevention products

June 7, 2017

Since June 2016, MPii has worked closely with the USAID/Namibia mission and Namibian Ministry of Health and Social Services to provide technical assistance and support for the country’s HIV prevention programs. Namibia’s National Strategic Framework (NSF) for HIV/AIDS emphasizes a comprehensive package of HIV prevention services. In July 2016, representatives from USAID/HQ and OPTIONS met… Read more »

Read more >

CHARISMA – June 2017

June 7, 2017

CHARISMA supports efforts to: increase women’s agency to safely use ARV-based HIV prevention, to engage male partners in HIV prevention, and to overcome harmful gender norms and reduce intimate partner violence (IPV). Clinic- and community-based interventions continue. Intervention evaluations and reporting planned. Clinic- and community-based interventions continue. CHARISMA is piloting its clinic-based intervention as part… Read more »

Read more >

POWER – June 2017

June 7, 2017

POWER develops cost-effective and scalable models for implementation of ARV-based HIV prevention products for women. Mental models community surveys completed. Training for POWER’s PrEP delivery cohort completed in Cape Town, Johannesburg, and Kisumu. Site activation scheduled. My PrEP decision support tool undergoes cognitive testing. Mental models community surveys completed. As part of the mental models… Read more »

Read more >